Home

Surmodics, Inc. - Common Stock (SRDX)

29.27
-0.84 (-2.79%)
NASDAQ · Last Trade: Apr 5th, 12:11 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Privatebenzinga.com
This week's Deal Dispatch has updates on Raizen, Walgreens, TikTok and Canoo. Plus: the FTC is blocking mergers like it's 2017 again.
Via Benzinga · March 7, 2025
Why Surmodics Stock Is Falling On Fridaybenzinga.com
Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR.
Via Benzinga · March 7, 2025
Top 3 Health Care Stocks You'll Regret Missing This Monthbenzinga.com
Via Benzinga · February 6, 2025
Surmodics Earnings Analysis: Q1 Recapbenzinga.com
Via Benzinga · January 30, 2025
SRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q3 2024investorplace.com
SRDX stock results show that Surmodics beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Via InvestorPlace · July 31, 2024
Assessing Surmodics: Insights From 5 Financial Analystsbenzinga.com
Via Benzinga · May 30, 2024
A Preview Of Surmodics's Earningsbenzinga.com
Via Benzinga · January 31, 2024
Why Shares of Surmodics Jumped This Weekfool.com
The company gained FDA marketing approval for a drug-coated balloon that will help clear blocked arteries.
Via The Motley Fool · June 23, 2023
Why Shares of Surmodics Soared on Tuesdayfool.com
An analyst upgrade gave the stock a boost.
Via The Motley Fool · June 13, 2023
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 29, 2024
Surmodics Stock Rockets, But Merck Stock Little Moved, On Takeover Dealsinvestors.com
Surmodics stock hit a two-year high on its GPCR takeover, but Merck stock was little moved on its EyeBio deal.
Via Investor's Business Daily · May 29, 2024
Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?benzinga.com
Surmodics will be acquired by GTCR for $43.00 per share, totaling $627 million. This 41.1% premium reflects Surmodics' advancements in surface modification for medical devices and IVD technologies.
Via Benzinga · May 29, 2024
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
Via Benzinga · May 29, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 29, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · May 1, 2024
SRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q2 2024investorplace.com
SRDX stock results show that Surmodics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · May 1, 2024
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 1, 2024
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
Via Benzinga · May 1, 2024
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
Via Benzinga · February 1, 2024
DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
U.S. stocks traded lower, with the Dow Jones dropping around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via Benzinga · June 20, 2023
Earnings Scheduled For February 1, 2024benzinga.com
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on revenue of $75.66 billion.
Via Benzinga · February 1, 2024
Earnings Scheduled For November 8, 2023benzinga.com
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Via Benzinga · November 8, 2023
After FDA Rejection, Surmodics' SurVeil Drug-Coated Balloon Scores FDA Approvalbenzinga.com
The FDA has approved Surmodics Inc's (NASDAQ: SRDX) SurVeil drug-coated balloon (DCB), a next-generation device 
Via Benzinga · June 20, 2023
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares gained 79.5% to $0.2740.
Via Benzinga · June 20, 2023
Second Time May Be a Charm: Analyst Is Bullish As Surmodics Resubmits SurVeil DCB Applicationbenzinga.com
In an investor presentation, Surmodics Inc (NASDAQ: SRDX) said it submitte
Via Benzinga · June 13, 2023